Can mapping a rare Gene's effects pave the way to targeted epilepsy therapies?

This study follows children aged 6 to 21 who have a CNKSR2 gene mutation, which can cause epilepsy, language difficulties, and intellectual disability. Researchers will use brain scans, EEGs, and developmental tests to track how the condition changes over time. The goal is to create a detailed picture of the disorder that could serve as a baseline for future trials of precision medicines.